Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia

被引：0
|
作者：
Ching-Yen Tsai
Chen-Hsiang Lee
I-Ling Chen
机构：
[1] Kaohsiung Chang Gung Memorial Hospital,Department of Internal Medicine, Division of Infectious Diseases
[2] Chang Gung University College of Medicine,Department of Pharmacy
[3] Kaohsiung Chang Gung Memorial Hospital,undefined
[4] School of Pharmacy,undefined
[5] Kaohsiung Medical University,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
β-Lactam; Teicoplanin; Clinical outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia
    Tsai, Ching-Yen
    Lee, Chen-Hsiang
    Chen, I-Ling
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [2] Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
    Monogue, Marguerite L.
    Ortwine, Jessica K.
    Wei, Wenjing
    Eljaaly, Khalid
    Bhavan, Kavita P.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (05) : 727 - 731
  • [3] Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
    Davie Wong
    Titus Wong
    Marc Romney
    Victor Leung
    Annals of Clinical Microbiology and Antimicrobials, 15
  • [4] Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia
    Kim, Sung-Han
    Kim, Kye-Hyung
    Kim, Hong-Bin
    Kim, Nam-Joong
    Kim, Eui-Chong
    Oh, Myoung-Don
    Choe, Kang-Won
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) : 192 - 197
  • [5] β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins
    Li, Julius
    Echevarria, Kelly L.
    Traugott, Kristi A.
    PHARMACOTHERAPY, 2017, 37 (03): : 346 - 360
  • [6] DEVASTATING METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA WITH AN UNKNOWN SOURCE
    Kagita, Navyamani V.
    Thota, Vihitha
    Jain, Akhil
    Ikoro, Udunma N.
    Sheu, Wei-Chun
    Russell, Steven
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S324 - S324
  • [7] Cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia in Japan
    Shoji, Takayo
    Hirai, Yuji
    Osawa, Makiko
    Totsuka, Kyoichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (3-4) : 175 - 180
  • [8] Impact of agr Functionality on the Outcome of Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Lee, Jeong Eun
    Lee, Shinwon
    Park, Sohee
    Lee, Soon O.
    Lee, Sun H.
    MICROBIOLOGY SPECTRUM, 2021, 9 (01): : 1 - 10
  • [9] Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?
    Karchmer, Adolf W.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (01) : 107 - 109
  • [10] Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
    Schweizer, Marin L.
    Furuno, Jon P.
    Harris, Anthony D.
    Johnson, J. Kristie
    Shardell, Michelle D.
    McGregor, Jessina C.
    Thom, Kerri A.
    Cosgrove, Sara E.
    Sakoulas, George
    Perencevich, Eli N.
    BMC INFECTIOUS DISEASES, 2011, 11
12345